Background: Limited guidelines exist for breast cancer management in developing
countries. In this context, the Women′ s Cancer Initiative-Tata Memorial Hospital (WCI …

Abstract The Global Cancer Genomics Consortium (GCGC) is an international collaborative
platform that amalgamates cancer biologists, cutting-edge genomics, and high-throughput …

Breast cancer is an increasingly recognized public health concern in developing countries.
The clinical spectrum is heterogeneous but largely characterized at presentation by a more …

There appears to be a broad consensus that estrogen is a cause of breast cancer. Proof of
cause and effect in clinical medicine requires a different approach for an epidemiological …

In patients with breast cancer, a number of biomarkers, such as estrogen receptor,
progesterone receptor and HER2, are part of routine work-up and used to guide endocrine …